Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP1A2 | P05177 | 1/20 | 0.42 |
| ▸ | PPARG | P37231 | 14/20 | 0.41 |
| ▸ | PPARA | Q07869 | 12/20 | 0.41 |
| ▸ | SRR | Q9GZT4 | 2/20 | 0.41 |
| ▸ | ALPI | P09923 | 1/20 | 0.40 |
| ▸ | PKM | P14618 | 1/20 | 0.40 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.40 |
| ▸ | XIAP | P98170 | 1/20 | 0.40 |
| ▸ | SLC7A5 | Q01650 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6010274 | 0.89 | SLC7A5 (0.43) | PPARGPPARASLC7A5 | |
| SCHEMBL6010156 | 0.79 | OR51E2 (0.34) | — | |
| SCHEMBL6010164 | 0.78 | SMN1; SMN2 (0.56) | PKM | |
| SCHEMBL6009878 | 0.77 | CYP1A2 (0.46) | CYP1A2SRRALPIPKMPTGS1 | |
| SCHEMBL6009856 | 0.77 | CYP1A2 (0.46) | CYP1A2SRRALPIPKMPTGS1 | |
| SCHEMBL6009483 | 0.75 | TET2 (0.38) | CYP1A2 | |
| SCHEMBL3248704 | 0.74 | CYP1A2 (0.50) | CYP1A2PPARGPPARASRRALPI | |
| SCHEMBL472008 | 0.74 | CYP1A2 (0.50) | CYP1A2PPARGPPARASRRALPI | |
| SCHEMBL6009578 | 0.73 | MME (0.36) | SLC7A5 | |
| SCHEMBL6009582 | 0.73 | CYP3A4 (0.48) | PKMSLC7A5 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20060018864-A1 | Cosmetic preparation containing glycerylamino acid derivative | SEIWA KASEI COMPANY, LIMITED (JP) | 2006-01-26 | — | — | US | disclosed |
| EP-1584320-A1 | COSMETIC PREPARATION CONTAINING GLYCERYLAMINO ACID DERIVATIVE | Seiwa Kasei Company, Limited (JP) | 2005-10-12 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060018864-A1 | Cosmetic preparation containing glycerylamino acid derivative | GLA, GPKOW, CUTA | CYP1A2 3183/4885PPARG 118/4885PPARA 378/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.